We are live on ! Find out more
SIA

Sit Investment Associates Portfolio holdings

AUM $4.93B
1-Year Est. Return 12.22%
This Fund
S&P 500
This Quarter Est. Return
+5.44%
1 Year Est. Return
+12.22%
3 Year Est. Return
+41.16%
5 Year Est. Return
+31.78%
10 Year Est. Return
+136.16%
AUM
$6.02B
AUM Growth
+$294M
Cap. Flow
+$56.1M
Cap. Flow %
0.93%
Top 10 Hldgs %
17.24%
Holding
472
New
43
Increased
114
Reduced
214
Closed
47

Top Buys

Rank Stock Value
1
ZBH icon
Zimmer Biomet
ZBH
+$53.7M
2
ITW icon
Illinois Tool Works
ITW
+$43.4M
3
SBUX icon
Starbucks
SBUX
+$40.5M
4
PACW
PacWest Bancorp
PACW
+$39.5M
5
HRB icon
H&R Block
HRB
+$35.1M

Top Sells

Rank Stock Value
1
CVX icon
Chevron
CVX
+$48.9M
2
RTX icon
RTX Corp
RTX
+$46.6M
3
USB icon
US Bancorp
USB
+$45.3M
4
IBM icon
IBM
IBM
+$41.4M
5
AET
Aetna Inc
AET
+$33.2M

Sector Composition

Rank Sector Weight
1 Healthcare 16.29%
2 Industrials 12.66%
3 Technology 12.06%
4 Financials 9.53%
5 Consumer Discretionary 9.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVSA
276
Covista Inc
CVSA
$4.8B
$1.84M 0.03%
38,850
-3,110
-7% -$146K
FMC icon
277
FMC
FMC
$1.33B
$1.8M 0.03%
36,435
-6,572
-15% -$320K
CF icon
278
CF Industries
CF
$17.3B
$1.74M 0.03%
31,875
-8,675
-21% -$457K
VCV icon
279
Invesco California Value Municipal Income Trust
VCV
$522M
$1.7M 0.03%
132,368
+50,900
+62% +$636K
VRTX icon
280
Vertex Pharmaceuticals
VRTX
$126B
$1.69M 0.03%
14,200
JAZZ icon
281
Jazz Pharmaceuticals
JAZZ
$16.7B
$1.69M 0.03%
10,300
WFC icon
282
Wells Fargo
WFC
$264B
$1.68M 0.03%
30,575
AMN icon
283
AMN Healthcare
AMN
$1.4B
$1.67M 0.03%
85,225
-6,715
-7% -$115K
CRZO
284
DELISTED
Carrizo Oil & Gas Inc
CRZO
$1.67M 0.03%
40,100
-3,225
-7% -$145K
SCOR icon
285
Comscore
SCOR
$109M
$1.59M 0.03%
1,718
-138
-7% -$116K
RBC icon
286
RBC Bearings
RBC
$18B
$1.58M 0.03%
24,554
-1,930
-7% -$117K
WBK
287
DELISTED
Westpac Banking Corporation
WBK
$1.58M 0.03%
58,790
-3,800
-6% -$107K
ICE icon
288
Intercontinental Exchange
ICE
$84.4B
$1.58M 0.03%
36,000
TW
289
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
$1.57M 0.03%
13,900
ATHN
290
DELISTED
Athenahealth, Inc.
ATHN
$1.49M 0.02%
10,250
-833
-8% -$105K
IQI icon
291
Invesco Quality Municipal Securities
IQI
$534M
$1.49M 0.02%
119,243
+42,679
+56% +$528K
SKX
292
DELISTED
Skechers
SKX
$1.47M 0.02%
+79,950
New +$1.49M
CSL icon
293
Carlisle Companies
CSL
$15.4B
$1.47M 0.02%
16,300
AMCX icon
294
AMC Global Media
AMCX
$489M
$1.46M 0.02%
22,900
JWN
295
DELISTED
Nordstrom
JWN
$1.45M 0.02%
18,300
ABUS icon
296
Arbutus Biopharma
ABUS
$915M
$1.44M 0.02%
+95,050
New +$1.64M
TT icon
297
Trane Technologies
TT
$106B
$1.44M 0.02%
22,700
+7,700
+51% +$470K
FLS icon
298
Flowserve
FLS
$10.2B
$1.39M 0.02%
23,300
-59,550
-72% -$3.79M
TECH icon
299
Bio-Techne
TECH
$11.3B
$1.36M 0.02%
58,700
-18,940
-24% -$433K
XOM icon
300
ExxonMobil
XOM
$634B
$1.35M 0.02%
14,582

Similar funds

Sit Investment Associates's Q4 2014 Portfolio in Review

As of Q4 2014, Sit Investment Associates held 472 positions worth $6.02B, up 5.1% from $5.73B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Sit Investment Associates's Q4 2014 filing shows 43 new, 114 increased, 214 reduced and 47 closed positions. Its largest new stake was Zimmer Biomet: 509,391 shares worth $56.1M. The largest sale was Chevron, an estimated $48.9M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Industrials and Technology.

  • Sit Investment Associates's largest Q4 2014 buy was Zimmer Biomet: 509,391 shares worth $56.1M.
  • Sit Investment Associates added most to Starbucks in Q4 2014, an estimated $40.5M increase.
  • Sit Investment Associates's biggest Q4 2014 reduction was Chevron, cutting an estimated $48.9M.
  • Sit Investment Associates fully exited Aetna Inc in Q4 2014, selling an estimated $33.2M.
  • Sit Investment Associates's ten largest holdings make up 17% of its $6.02B portfolio in Q4 2014.
  • Sit Investment Associates opened 43 new positions and closed 47 in Q4 2014.
  • Sit Investment Associates's portfolio value rose 5.1% quarter-over-quarter to $6.02B.

Based on Sit Investment Associates's 13F filing for Q4 2014, filed 28 Jan 2015.